An enhancement has been incorporated in Labs Beta View. When the user opens the result flowsheet in Labs Beta View, an information icon is displayed next to the test name by using LOINC as the standard. This ensures that the user has more information available about the specific test.
With this enhancement in the CureMD application, the user is able to view the bulk charge logs in the Charges Logs. This provides a consistent, unified view of transactions and ensures that the user finds the same logs on Charges Section just as Appointment Status.
With this enhancement, only the short form of location’s name is populated on the radiology order requisition created by Digestive Disease Care. This ensure that only one short form of location is displayed on the requisition instead of both long and short form which takes a lot of space.
With this enhancement in the CureMD application, additional screening forms have been added to assessments. This helps users evaluate the severity of patient’s condition.
With this enhancement, users can now view the procedure level information on the printed report of a pending problematic appointment in the problem list section. This ensures that complete (appointment level and procedure level) information is displayed on the printed report and shared with concerned parties for resolution.
With this enhancement in the CureMD application, users can download and install version 6.0 of CureMD Client Utility containing the latest updates. The updates enhance the security and performance of the utility.
Patient tags have been introduced in the Chemotherapy Manager to ensure that all patient tags relevant to a patient profile are displayed in the chemotherapy manager. This enhancement helps in compiling the information when the user looks up a patient, an order or an admin by leveraging the relevant tags.
Following are the enhanced areas in this feature:
With this enhancement, the system supports the latest versions of the American Joint Committee on Cancer (AJCC) cancer staging (versions 8 and 9). This ensures that through the AJCC cancer staging, the healthcare professionals have the ability to document the clinical data related to a patient's cancer stage.
Enhancements have been made to the Adverse Events Module in the Chemotherapy Manager including Resolution Reason for Adverse Event, Serious Adverse Event and Relationship Section.
In line with new CMS guidelines effective July 1, 2023, healthcare practices need to use the JZ modifier when billing for drugs, specifically when no amount is discarded from a single-dose container. This requirement applies to all such claims that are submitted by the practices. Hence, to ensure that the billing process complies with this requirement, JZ modifier has been introduced to the Chemotherapy Manager.
Posted On: Jul 18, 2023
Posted On: Jul 18, 2023
Posted On: Jul 18, 2023
Posted On: Jul 18, 2023
Posted On: Jul 18, 2023
Posted On: Jul 18, 2023